mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |